Columbus Regional Health is pleased to offer the OmniaSecure™ defibrillation lead, a novel advancement in transvenous ...
Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronization, according to a Late-Breaking Science presentation at EHRA 2026, the annual congress of ...
MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...
Newer pacing method matched standard cardiac resynchronization therapy with respect to clinical outcomes in the first ...
Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
A recent systematic review has evaluated the efficacy, effectiveness and safety of cardiac resynchronization therapy (CRT; using atrial-synchronized biventricular pacemakers) in patients with heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results